Risk Reduction to Disease Management: Clinical Pharmacists as Cardiovascular Care Providers

被引:4
作者
Di Palo, Katherine E.
Patel, Khusbu
Kish, Troy
机构
关键词
EMERGENCY-MEDICINE PHARMACIST; TO-NEEDLE TIME; HEART-FAILURE; RANDOMIZED-TRIAL; MYOCARDIAL-INFARCTION; PATIENT-OUTCOMES; AMERICAN-COLLEGE; UNITED-STATES; IMPACT; SMOKING;
D O I
10.1016/j.cpcardiol.2018.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most cardiovascular diseases are caused by modifiable risk factors yet prevalence continues to increase and heart disease remains the leading cause of death in the United States. Screening, identifying and appropriately managing high risk patients are strategies to shift the paradigm from treatment to prevention. Pharmacists are an underutilized population health resource despite robust evidence to support their roles as interdisciplinary team members and direct patient care providers in both inpatient and outpatient settings. This article aims to highlight the multifaceted function and impact of clinical pharmacists on cardiovascular risk reduction and disease management.
引用
收藏
页码:276 / 292
页数:17
相关论文
共 79 条
[41]   Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team - Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study [J].
Gattis, WA ;
Hasselblad, V ;
Whellan, DJ ;
O'Connor, CM .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (16) :1939-1945
[42]   PHARMACIST IMPACT ON ISCHEMIC STROKE CARE IN THE EMERGENCY DEPARTMENT [J].
Gosser, Rena A. ;
Arndt, Richard F. ;
Schaafsma, Kate ;
Dang, Cathyyen H. .
JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (01) :187-193
[43]  
Groth Christine M, 2016, J Pharm Pract, V29, P116, DOI 10.1177/0897190014544794
[44]   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [J].
Grundy, SM ;
Cleeman, JI ;
Merz, CNB ;
Brewer, HB ;
Clark, LT ;
Hunninghake, DB ;
Pasternak, RC ;
Smith, SC ;
Stone, NJ .
CIRCULATION, 2004, 110 (02) :227-239
[45]   Incidence and preventability of adverse drug events among older persons in the ambulatory setting [J].
Gurwitz, JH ;
Field, TS ;
Harrold, LR ;
Rothschild, J ;
Debellis, K ;
Seger, AC ;
Cadoret, C ;
Garber, L ;
Kelleher, M ;
Bates, DW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (09) :1107-1116
[46]   Health Care Expenditures and Therapeutic Outcomes of a Pharmacist-Managed Anticoagulation Service versus Usual Medical Care [J].
Hall, Deanne ;
Buchanan, Julianne ;
Helms, Bethany ;
Eberts, Matthew ;
Mark, Scott ;
Manolis, Chronis ;
Peele, Pamela ;
Docimo, Anne .
PHARMACOTHERAPY, 2011, 31 (07) :686-694
[47]   Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic [J].
Hirsch, Jan D. ;
Bounthavong, Mark ;
Arjmand, Anisa ;
Ha, David R. ;
Cadiz, Christine L. ;
Zimmerman, Andrew ;
Ourth, Heather ;
Morreale, Anthony P. ;
Edelman, Steven V. ;
Morello, Candis M. .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (03) :318-326
[48]   Primary Care-based, Pharmacist-physician Collaborative Medication-therapy Management of Hypertension: A Randomized, Pragmatic Trial [J].
Hirsch, Jan D. ;
Steers, Neil ;
Adler, David S. ;
Kuo, Grace M. ;
Morello, Candis M. ;
Lang, Megan ;
Singh, Renu F. ;
Wood, Yelena ;
Kaplan, Robert M. ;
Mangione, Carol M. .
CLINICAL THERAPEUTICS, 2014, 36 (09) :1244-1254
[49]   Emergency Medicine Pharmacist Impact on Door-to-Needle Time in Patients With Acute Ischemic Stroke [J].
Jacoby, Joshua S. ;
Draper, Heather M. ;
Dumkow, Lisa E. ;
Farooq, Muhammad U. ;
DeYoung, G. Robert ;
Brandt, Kasey L. .
NEUROHOSPITALIST, 2018, 8 (02) :60-65
[50]   Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents [J].
Jain, A ;
Mills, P ;
Nunn, LM ;
Butler, J ;
Luddington, L ;
Ross, V ;
Cliffe, P ;
Timmis, AD .
EUROPEAN JOURNAL OF HEART FAILURE, 2005, 7 (03) :405-410